Sort   by:  
 Page size 
UnknownConflicting genomic signals affect phylogenetic inference in four species of North American pines.
Not available
S-EPMC4866652 | biostudies-literature
UnknownThe trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
Not available
S-EPMC2958458 | biostudies-literature
UnknownAMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.
Not available
S-EPMC4666535 | biostudies-literature
UnknownQuality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Not available
S-EPMC2946862 | biostudies-literature
UnknownA multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.
Not available
S-EPMC7443368 | biostudies-literature
UnknownNivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
Not available
S-EPMC10115555 | biostudies-literature
UnknownTherapeutic inhibition of USP7 promotes antitumor immune responses.
Not available
S-EPMC12481409 | biostudies-literature
UnknownHealth-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.
Not available
S-EPMC9847563 | biostudies-literature
UnknownIncreased core body temperature in astronauts during long-duration space missions.
Not available
S-EPMC5701078 | biostudies-literature
UnknownEfficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Not available
S-EPMC10582968 | biostudies-literature
Sort   by:  
 Page size